[HTML][HTML] Multicenter case–control study of COVID-19–associated mucormycosis outbreak, India

V Muthu, R Agarwal, SM Rudramurthy… - Emerging Infectious …, 2023 - ncbi.nlm.nih.gov
In support of improving patient care, this activity has been planned and implemented by
Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited with …

Multimodal analysis of the COVID‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors

A Chowdhary, N Gupta, S Wurster, R Kumar… - Mycoses, 2023 - Wiley Online Library
Background The aetiology of the major outbreak of COVID‐19‐associated mucormycosis
(CAM) in India in spring 2021 remains incompletely understood. Herein, we provide a …

Virulence traits and novel drug delivery strategies for mucormycosis post-COVID-19: a comprehensive review

M Faiyazuddin, A Sophia, S Ashique… - Frontiers in …, 2023 - frontiersin.org
The outbreak of a fatal black fungus infection after the resurgence of the cadaverous COVID-
19 has exhorted scientists worldwide to develop a nutshell by repurposing or designing new …

Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study

D Garg, K Soundappan, R Agarwal, S Mukherjee… - Mycoses, 2023 - Wiley Online Library
Background Factors associated with pulmonary mucormycosis (PM) among subjects with
diabetes mellitus (DM) remain unclear. Following the coronavirus disease (COVID‐19) …

Post-COVID-19 rhino-orbito-cerebral mucormycosis—A clinico-mycological study from North India

J Taneja, K Chatterjee, J Sasidharan… - Medical …, 2023 - academic.oup.com
The second wave of coronavirus disease 2019 (COVID-19), during the early 2021, lead to a
devastating outbreak of mucormycosis in India. This study aimed to determine the aetiology …

[HTML][HTML] COVID-19, mucormycosis, and the cow: Damned lies!

V Muthu, R Agarwal, A Chakrabarti - Indian Journal of Medical …, 2023 - ncbi.nlm.nih.gov
Mucormycosis, a deep-seated mycosis associated with high mortality, affects individuals
with compromised immunity [1]. While an uncommon invasive infection, an epidemic of …

Mucormycosis in a Patient with Severe COVID-19 Disease—The First Case Report in Romania and a Literature Review

B Mahler, OA Parliteanu, O Alexe, C Rîșcă Popazu… - Medicina, 2023 - mdpi.com
Introduction: COVID-19 infection is often associated with a vast spectrum of opportunistic
bacterial and fungal infections. Herein, we share a summary of the first case of COVID-19 …

Mucormycosis: a rare disease to notifiable disease

S Panda, MC Sahu, J Turuk, S Pati - Brazilian Journal of Microbiology, 2024 - Springer
Mucormycosis is the third most frequent invasive mycosis, following candidiasis and
aspergillosis. It is frequently neglected due to its rare occurrence; but recently attend the …

[HTML][HTML] Quality of life in patients treated for COVID-19–associated mucormycosis at a tertiary care hospital

P Kumar, RR Ur, N Roy, D Agrawal… - Osong Public Health …, 2023 - ncbi.nlm.nih.gov
Objectives Coronavirus disease 2019 (COVID-19)–associated mucormycosis (CAM) has
emerged as a formidable infection in patients with COVID-19. The aggressive management …

Baseline findings of a multicentric ambispective cohort study (2021–2022) among hospitalised mucormycosis patients in India

RS Abdulkader, M Ponnaiah, T Bhatnagar… - Mycology, 2024 - Taylor & Francis
In India, the incidence of mucormycosis reached high levels during 2021–2022, coinciding
with the COVID-19 pandemic. In response to this, we established a multicentric …